Ganglion cyst of the temporomandibular joint with intradural extension: case report.

J Neurosurg

4Goodman Campbell Brain and Spine, Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, Indiana.

Published: March 2020

Intracranial extension of temporomandibular joint (TMJ) ganglion cysts is very rare. Two previously reported cases presented clinically due to effects on cranial nerves and had obvious association with the TMJ on imaging. To the authors' knowledge, intracranial extension of a TMJ ganglion cyst presenting with seizures and mimicking a primary brain tumor has not been previously reported. The patient underwent resection of a presumptive primary cystic temporal lobe tumor, but the lesion had histopathological features of a nonneoplastic cyst with a myxoid content. He was followed with serial imaging for 5 years before regrowth of the lesion caused new episodes of seizures requiring a repeat operation, during which the transdural defect was repaired after the adjacent segment of the TMJ was curetted. A thorough review of all imaging studies and the histopathological findings from the repeat operation led to the correct diagnosis of a TMJ ganglion cyst. This case highlights an unusual presentation of this rare lesion, as well as its potential for recurrence. TMJ ganglion cysts should be included in the differential diagnosis of cystic tumors involving the anterior temporal lobe, presenting with or without seizures. Focused imaging evaluation of the TMJ can be helpful to rule out the possible role of associated TMJ lesions.

Download full-text PDF

Source
http://dx.doi.org/10.3171/2018.10.JNS182665DOI Listing

Publication Analysis

Top Keywords

tmj ganglion
16
ganglion cyst
12
temporomandibular joint
8
intracranial extension
8
tmj
8
ganglion cysts
8
presenting seizures
8
temporal lobe
8
repeat operation
8
ganglion
5

Similar Publications

Bafilomycin A1 mitigates subchondral bone degeneration and pain in TMJOA rats.

Int Immunopharmacol

January 2025

Department of Oral and Maxillofacial Surgery, State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education School and Hospital of Stomatology, Wuhan University, Wuhan, Hubei, China. Electronic address:

Background: Pain and disability are primary concerns for temporomandibular joint osteoarthritis (TMJOA) patients, and the efficacy of current treatments remains controversial. Overactive osteoclasts are associated with subchondral bone degeneration and pain in OA. The vacuolar H+-ATPase (V-ATPase) is crucial for differentiation and function in osteoclasts, but its role in TMJOA is not well defined.

View Article and Find Full Text PDF

Temporomandibular disorder (TMD) is the most prevalent painful condition in the craniofacial area. Recent studies have suggested that external or intrinsic trauma to the temporomandibular joint (TMJ) is associated with the onset of painful TMD in patients. Here, we investigated the effects of TMJ trauma through forced-mouth opening (FMO) in mice to determine pain behaviors and peripheral sensitization of trigeminal nociceptors in both sexes.

View Article and Find Full Text PDF

Ganglions are pseudocysts that develop from part of the joint capsule or tendon sheath and are filled with synovial fluid. In this report, we describe a case of external auditory canal obstruction caused by a temporomandibular joint (TMJ) ganglion that was thought to be related to osteoarthritis. A 62-year-old man with the chief complaint of swelling of the anterior wall of the left external auditory canal underwent cystectomy at the Department of Otorhinolaryngology.

View Article and Find Full Text PDF

C2230, a preferential use- and state-dependent CaV2.2 channel blocker, mitigates pain behaviors across multiple pain models.

J Clin Invest

December 2024

Department of Pharmacology and Therapeutics, College of Pharmacy, University of Florida, Gainesville, United States of America.

Article Synopsis
  • - Antagonists like Ziconotide and Gabapentin target CaV2.2 calcium channels to relieve chronic pain, but their clinical use is limited due to issues like narrow therapeutic windows and potential for misuse or side effects.
  • - A new compound called C2230 has been identified as a blocker of CaV2.2 channels, showing multiple beneficial effects such as trapping the channel in an inactivated state and specifically targeting pain without affecting other ion channels or motor functions.
  • - C2230 effectively reduced pain-like behaviors in various animal models and human neurons, suggesting it could be developed as a new analgesic with a unique binding mechanism that differentiates it from existing treatments.
View Article and Find Full Text PDF
Article Synopsis
  • * Patients with this pain condition show central sensitisation, leading to abnormal sensitivity to pain even without visible inflammation.
  • * The review discusses how changes in neuronal ion channels, such as TRPV1 and NMDA receptors, are linked to the altered nociception in myofascial orofacial pain, reinforcing the idea of nociplastic mechanisms at play.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!